Global Biologics and Biosimilars Supply, Demand and Key Producers, 2023-2029

Global Biologics and Biosimilars Supply, Demand and Key Producers, 2023-2029

The global Biologics and Biosimilars market size is expected to reach $ 843370 million by 2029, rising at a market growth of 8.3% CAGR during the forecast period (2023-2029).

Global key biologics and biosimilars manufacturers include Johnson & Johnson, Pfizer, Roche, Amgen, AbbVie, and others. The top five manufacturers together account for approximately 50% of the market share, with the largest manufacturer being Pfizer with over 20% share. In terms of product categories, monoclonal antibodies are the largest segment with a market share of 43%, followed by vaccines with a 30% share. In terms of applications, hospitals are the top application area, with about 85% of the market share.

Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) products.

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original "innovator" products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.

This report studies the global Biologics and Biosimilars demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Biologics and Biosimilars, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biologics and Biosimilars that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Biologics and Biosimilars total market, 2018-2029, (USD Million)

Global Biologics and Biosimilars total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Biologics and Biosimilars total market, key domestic companies and share, (USD Million)

Global Biologics and Biosimilars revenue by player and market share 2018-2023, (USD Million)

Global Biologics and Biosimilars total market by Type, CAGR, 2018-2029, (USD Million)

Global Biologics and Biosimilars total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Biologics and Biosimilars market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biologics and Biosimilars market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Biologics and Biosimilars Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Biologics and Biosimilars Market, Segmentation by Type
Monoclonal Antibodies
Interferon
Insulin
Vaccines
Others

Global Biologics and Biosimilars Market, Segmentation by Application
Hospital
Retail Pharmacy
Other

Companies Profiled:
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Biogen
Celltrion
Sobi
3SBIO
Changchun High Tech
Kanghong Pharma
Innovent Biologics
Gan&Lee
Tonghua Dongbao
United Laboratory

Key Questions Answered

1. How big is the global Biologics and Biosimilars market?

2. What is the demand of the global Biologics and Biosimilars market?

3. What is the year over year growth of the global Biologics and Biosimilars market?

4. What is the total value of the global Biologics and Biosimilars market?

5. Who are the major players in the global Biologics and Biosimilars market?

6. What are the growth factors driving the market demand?